NEW YORK, Dec 16- Comcast Corp is examining three scenarios for a potential deal with Time Warner Cable, including a full takeover bid for the second-largest cable operator, people close to the situation said on Monday.» Read More
Dr. Leonard Schleifer, Regeneron Pharmaceuticals president & CEO, discusses competition in the pharma sector and upcoming clinical trials. "One of the things that's particularly exciting for a lot of people is our approach to lowering cholesterol," says Schleifer.
CNBC's Seema Mody discusses the details of the deal between pharma companies Bristol-Myers and Amylin.
CNBC's Scott Cohn reports on what the Justice Department calls the biggest health care fraud settlement in U.S. history; and CNBC's Seema Mody reports on the details of Bristol-Myers' plans to buy Amylin.
CNBC's David Faber reports the latest details on the takeover deal between German health care company Fresenius and Rhoen-Klinikum.
CNBC's Kayla Tausche reports Grupo Modelo has confirmed it is in talks on expanding its relationship with Anheuser-Busch.
Insight Venture Partners is currently working on a revision of its bid for Quest Software, reports CNBC's Kayla Tausche.
Campbell Dawson, Portfolio Manager, Elstree Investment Management advises investors go into defensives and fixed-income, adding that the euro debt crisis could drag on another 2 years.
Frank Sennett, "Groupon's Biggest Deal Ever" author, discusses Groupon's decision to decline Google's $6 billion bid back in 2010 and weighs in on the future of the deal-of-the-day company.
Four directors at Chesapeake Energy will resign from the company's board following discussions with Carl Icahn. CNBC's Kate Kelly has the details.
The FMHR traders share their top three trades of the hour, including shares of Avon moving higher on news it will consider Coty's takeover bid. Mark Mahaney, Citigroup internet analyst, also forecasts Groupon's earnings performance.
CNBC's David Faber reports Elliot International notified BMC Software it intends to nominate a slate of five board members and billionaire investor Carl Icahn is ready to disclose his stake in Chesapeake Energy.
The "Squawk on the Street" team discusses this morning's major headlines, including European stocks on the rebound, Coty's higher bid for Avon, and a new revelation from Facebook.
CNBC's Tyler Mathisen reports shares of P.F. Chang's are moving higher on news the Chinese food chain is being bought by Centerbridge Partners. Jeff Kilburg, Kilburg Capital, weighs in on other takeover targets.
CNBC's David Faber speaks to activist investor Carl Icahn regarding how much cash he has available to invest and whether Chesapeake Energy is undervalued.
Human Genome Sciences rejected the $2.6 billion unsolicited takeover bid from GlaxoSmithKline, reports CNBC's Herb Greenberg.
CNBC's Kayla Tausche reports on Illumina playing offense against Roche's hostile takeover bid, and the FMHR crew share their final trades of the hour.
CNBC's David Faber reports the latest details on Illumina's recommendation to shareholders to reject Roche's takeover offer.
Mad Money host Jim Cramer shares his final thoughts on the future of tech giants, Research in Motion and Yahoo.
The play on Research in Motion, and whether it's a prime takeover target, with the Fast Money crew.
Mad Money host Jim Cramer shares two things he thinks have to happen to save Avon: get rid of Jung, and ignore Coty's bid.